Offer - Urjas Oil for just ₹ 1
Mycurit Z is a commercial drug that is prescribed in the form of Tablet. Tuberculosis are some of its major therapeutic uses.
Medical history of the patient along with age and gender determines the dosage of Mycurit Z. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
Common side effects of Mycurit Z include Rash, Erythema, Discoloration of Urine. While these are the most often observed Mycurit Z side effects, there are can be others also. These have been listed below. These side effects of Mycurit Z are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Mycurit Z's effect is Moderate during pregnancy and Moderate for lactating mothers. In addition, Mycurit Z's effects on the liver, heart and kidney are discussed below in the Mycurit Z related warnings section.
Some other conditions that can be affected by Mycurit Z are listed in the contraindications section below.
Drug reaction of Mycurit Z with other medicines has been reported. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Mycurit Z is not safe while driving, and is is not addictive in nature.
Mycurit Z is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
| Adult |
|
| Geriatric |
|
Is the use of Mycurit Z safe for pregnant women?
Mycurit Z can have harmful effects in pregnant women. If you experience any discomfort after using Mycurit Z, then discontinue the use and take your doctor's advice.
Is the use of Mycurit Z safe during breastfeeding?
Mycurit Z may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Mycurit Z, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Mycurit Z.
What is the effect of Mycurit Z on the Kidneys?
Mycurit Z may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Mycurit Z on the Liver?
You may experience side effects on your liver after taking Mycurit Z. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Mycurit Z on the Heart?
You may experience side effects on your heart after taking Mycurit Z. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
Mycurit Z should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Mycurit Z unless your doctor advises you to do so -
Is this Mycurit Z habit forming or addictive?
No, you will not get addicted to Mycurit Z.
Is it safe to drive or operate heavy machinery when consuming?
After taking Mycurit Z you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Mycurit Z is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Mycurit Z is unable to treat or cure mental disorders.
Interaction between Food and Mycurit Z
Taking Mycurit Z with food is safe.
Interaction between Alcohol and Mycurit Z
Consult your doctor before consuming alcohol while taking Mycurit Z as it can have severe side effects.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Isoniazid
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 765-767
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 715-716
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 768-769
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1066-1067
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rifadin (rifampin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 767-768
Product Description [Internet]: RIFATER® (rifampin, isoniazid and pyrazinamide USP). USFDA
Product Description [Internet]: RIFADIN®. USFDA
Product Description [Internet]: ISONIAZID. Alliance Pharmaceuticals Limited
